|
1. Biologie
|
|
|
Reading between the lines [Nature]
|
|
|
|
|
|
The
researchers analysed cell lines from different sources, including the
popular MCF7 type used to investigate cancer. They found a staggering
amount of variation.
|
|
|
|
|
|
|
|
1.1 Biologie - Gènes
|
|
|
|
Elephants Have a Secret Weapon Against Cancer [The Atlantic]
|
|
|
|
|
|
Now,
when DNA gets damaged, p53 lands at the promoter and spurs LIF6 into
action. LIF6 then triggers that self-destruct sequence that sends
damaged cells to their doom. For good reason, Lynch calls it a zombie
gene—it used to be dead, it’s now reanimated, and it kills the cells
that rouse it.
|
|
|
|
|
|
|
2. Etiologie
|
|
|
|
2.11 Etiologie - Alimentation
|
|
|
|
2.6 Etiologie - Environnement
|
|
|
Glyphosate on Trial [McGill Office for Science and Society]
|
|
|
|
|
|
In
my opinion, science is on the side of glyphosate's benefits outweighing
its risks, but emotion is on the side of the plaintiff. And we have
often seen that emotion trumps science. Furthermore, the defendant in
this lawsuit, Monsanto, was essentially challenged to prove that Mr.
Johnson’s lymphoma was not caused by glyphosate. That is an impossible
task.
|
|
|
|
|
|
|
Courts don’t determine scientific facts [The Logic of Science]
|
|
|
|
|
|
Which
conclusion seems more reliable to you? The one that was arrived at by
experts spending months carefully and systematically examining all of
the available evidence, or the one that was arrived at by non-experts
basing a decision on a comparison of two extremely biased
representations of the evidence?
|
|
|
|
|
|
|
|
|
Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts [Reuters]
|
|
|
|
|
|
A
major question for appellate courts could be whether it is enough for
an expert to simply analyze widely accepted peer-reviewed studies to
support his own opinion, or whether the expert’s analysis must also be
reviewed or otherwise subject to stronger scrutiny, said two
California-based defense lawyers, who requested anonymity citing
potential conflicts of interest.
|
|
|
|
|
|
|
|
|
3.1 Prévention - Tabac
|
|
|
|
3.1.1 Prévention - Tabac - e-cigs
|
|
|
|
|
|
3.4 Chimioprévention
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
|
4.10 Dép., diag. & prono. - Poumon
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
4.5 Dép., diag. & prono. - Colorectal
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
|
5. Traitements
|
|
|
|
|
|
5.1 Traitements - Pré-clinique
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
|
5.12.2 Immunothérapies - CAR-T, thérapies cellulaires
|
|
|
|
5.12.6 Immunothérapies - AMM
|
|
|
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA,...)
|
|
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
6.1 Observation
|
|
|
|
Thousands of cancer patients face NHS treatment delays [The Guardian]
|
|
|
|
|
|
In
the 12 months to June, 130,553 people in England had to wait more than
two weeks for their first appointment with a cancer specialist after
being urgently referred by a GP. That was a big increase on the 104,930
who had to wait longer than 14 days in the same period in 2016-17
|
|
|
|
|
|
|
|
6.12 Ethique
|
|
|
The case against shared decision-making – 2 [Alert and Oriented]
|
|
|
|
|
|
On
the surface, it may seem to promote a dialogue between patients and
physicians that is too frequently neglected when doctors are
inordinately self-important. However, shared decision making only
muddies the waters of clinical decision-making and weakens the bond
uniting patients and doctors.
|
|
|
|
|
|
|
6.3 Associations/Fondations
|
|
|
|
6.6 Publications
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|
6.7.1 IA/bioinformatique
|
|
|
|
|
6.9 Controverses
|
|
|
|